1-2 of 2
Irena Preloznik Zupan
Close
Sort by
Journal Articles

Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia

Fermin Sanchez-Guijo, MD PhD, Sergio Matarraz, Eleni Plata, Miguel Sagüés, Montserrat Cortes, Irena Preloznik Zupan, Monica Crugnola, MD, Giovanni Caocci, MD, Heather Oakervee, BSc, MBBS, MD MRCP, FRCPath, Tobias Gedde-Dahl, Krzysztof Warzocha, Wieslaw W. Jedrzejczak, Slawomira Kyrcz-Krzemien, MD PhD, Alexander Kiani, Sharon Supekar, AnaRita Ferreira, Seema Shah, Juan Luis Steegmann, Michele Baccarani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4160.
https://doi.org/10.1182/blood-2019-124710
Published: 2019
Journal Articles

The European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML). A Prospective, Population-Based European Registry.

Michele Baccarani, Bengt Simonsson, Doris Lindörfer, Gianantonio Rosti, Antonio M Almeida, MD, PhD, Andrija Bogdanovic, Richard E. Clark, Adriana Colita, Paul A. Costeas, Laimonas Griskevicius, Joelle Guilhot, Andrzej Hellmann, MD, PhD, DSc, Karel Indrak, MD, PhD, Edward Laane, Boris Labar, MD, PhD, Tamas Masszi, MD, Sandra Lejniece, MD, Jiri Mayer, MD, Gert Ossenkoppele, Panayiotis Panayiotidis, Kimmo Porkka, MD, PhD, Susanne Saussele, Andreas Hochhaus, MD, Juan Luis Steegmann, MD, PhD, Josef Thaler, MD, Anna Turkina, Gregor Verhoef, Andrey Zaritskey, Irena Preloznik Zupan, Francesca Rancati, Lara Montrucchio, Rüdiger Hehlmann, Joerg Hasford
Journal: Blood
Blood (2009) 114 (22): 4272.
https://doi.org/10.1182/blood.V114.22.4272.4272
Published: 2009